Rathbones Group PLC Astrazeneca PLC Transaction History
Rathbones Group PLC
- $19 Billion
- Q3 2024
A detailed history of Rathbones Group PLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Rathbones Group PLC holds 13,703 shares of AZN stock, worth $976,201. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,703
Previous 13,478
1.67%
Holding current value
$976,201
Previous $1.05 Million
1.52%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,335Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.48 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.99 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.65 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.62 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.36 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $221B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...